Application in a Necrotizing Soft Tissue Infection of the Thigh
Michael Cormican, MD
Trauma Surgeon – Northeast Georgia Physicians Group. Northeast Georgia Medical Center – Gainesville, GA
Initial Assessment
Day 56
Results
- 100% take of STSG at 1 week
- Good tissue pliability and pigmentation
- No complications
Patient details
56-year-old trans-female
Medical history
Case details
- Description: Full thickness wound of the left posterior thigh with exposed hamstrings muscle and tendon
- Approximate Size: 21 x 10 x 2 cm
- Etiology: NSTI
Application photos
Myriad Application
- Multiple sharp debridement’s of non-viable tissue
- Applied Myriad Morcells (2000 mg) to irregular areas where the sheet could not make direct contact with the wound bed
- Multiple pieces of Myriad Matrix (10 x 20 cm, 5-Layer) were trimmed to size to cover entire wound bed. The pieces were rehydrated in sterile saline and secured with Xeroform® and suture
- Secondary dressing: NPWT at 125 mmHg
Day 8
- Myriad well adhered and integrating. Buds of granulation tissue were noted forming under Xeroform®
- Pain well controlled
- No complications
- Continued NPWT at 125 mmHg
Day 12
- Vascularized granulation tissue forming under Xeroform®
- No complications
- Continued NPWT at 125 mmHg
Day 28
- 100% vascularized, granular neodermis formed
- Small piece of residual Myriad noted to the distal medial aspect
- No complications
- Defect ready for planned split-thickness skin graft (STSG) application
Day 35
- STSG applied
- No complications
- Note donor site (arrow) adjacent to original defect
Day 56
- 100% Take of STSG at 1 week
- Good tissue pliability and pigmentation
- No complications
Results may vary. Dr. Cormican has a consultancy agreement with Aroa Biosurgery Limited.
Xeroform® is a trademark and property of the respective owner.